Quick Search:

uzh logo
Browse by:

The deadline for the annual report 2015 is January 31st, 2016

Zurich Open Repository and Archive

Maintenance: Tuesday, 16.2.2015, 06:00-08:00

Maintenance work on various system components of ZORA. During this time there will be a brief unavailability for about 1 hour. Please be patient.

Khanna, D; Seibold, J R; Wells, A; Distler, O; Allanore, Y; Denton, C; Furst, D E (2010). Systemic sclerosis-associated interstitial lung disease: Lessons from clinical trials, outcome measures, and future study design. Current Rheumatology Review, 6(2):138-144.

Full text not available from this repository.

View at publisher


Pulmonary involvement including interstitial lung disease (ILD) is the leading cause of mortality in patients with systemic sclerosis (scleroderma; SSc). This article reviews the current evidence based medicine regarding available therapies for SSc-ILD ; discusses the lessons learned from recent SSc-ILD randomized controlled trials (RCTs); and proposes outcome measures and recommendations for design of future RCTs for SSc-ILD.



Additional indexing

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Rheumatology Clinic and Institute of Physical Medicine
Dewey Decimal Classification:610 Medicine & health
Deposited On:02 Feb 2011 15:35
Last Modified:23 Nov 2012 12:51
Publisher:Bentham Science
Publisher DOI:10.2174/157339710791330768
PubMed ID:20676227

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page